HIV resistance to reverse transcriptase inhibitors

Biochem Pharmacol. 1994 Jan 20;47(2):155-69. doi: 10.1016/0006-2952(94)90001-9.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antiviral Agents / pharmacology*
  • Benzodiazepines / pharmacology
  • Dideoxynucleosides / pharmacology
  • Dose-Response Relationship, Drug
  • Drug Resistance / genetics
  • HIV Reverse Transcriptase
  • HIV-1 / drug effects*
  • HIV-1 / genetics
  • Humans
  • Imidazoles / pharmacology
  • Mutation
  • Nevirapine
  • Pyridines / pharmacology
  • Reverse Transcriptase Inhibitors*
  • Thymine / analogs & derivatives
  • Thymine / pharmacology

Substances

  • Antiviral Agents
  • Dideoxynucleosides
  • Imidazoles
  • Pyridines
  • Reverse Transcriptase Inhibitors
  • 1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine
  • Benzodiazepines
  • R-82913
  • Nevirapine
  • HIV Reverse Transcriptase
  • Thymine